Clinical Trial Update: Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a second dose of celecoxib for post-tooth extraction pain has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-tooth Extraction Pain

Drugs mentioned

• Celecoxib (YM177) (celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pain | Phase 2 | Status: COMPLETED | Results posted: 2012-11-19